Larvol Delta - Avacta-announces-rst-patient-treated-in-Phase-1-FOCUS01-trial-of-FAPExd-AVA6103--a-sustainedrelease-preCISION-exatecan-peptide-drug-conjugate

AVA-6103 - Avacta

https://www.manilatimes.net/2026/03/31/tmt-newswire/globenewswire/avacta-announces-first-patient-treated-in-phase-1-focus-01-trial-of-fap-exd-ava6103-a-sustained-release-precisionexatecan-peptide-drug-conjugate/2311108

Mar 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next